# NewAmsterdam Pharma Company N.V. (NAMS)

> Source: Nexqual · https://nexqual.com/NAMS · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, NewAmsterdam Pharma Company N.V. (NAMS), nexqual.com/NAMS" · informational, not investment advice.

**Price:** USD 20.62 (+3.05% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 20.01 · day 20.21–21.12 · 52w 19.58–42.21 · market cap $2.41B · NGM

## Key facts
- Analysts: Buy (mean 1.88 on a 1–5 scale) (16 analysts), mean target USD 49.82 (range 38.12–59.45).
- Total return with dividends: 1Y -43.5% vs S&P 500 +18.1%; 5Y +110.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-04, EPS estimate USD -0.44, revenue estimate $6.4M.

## Analysts
Consensus Buy (mean 1.88 on a 1–5 scale), 16 analysts; mean target USD 49.82 (low 38.12, high 59.45).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-05 | RBC Capital | Target lowered | Outperform | $50 → $42 |
| 2026-09-08 | HC Wainwright & Co. | Reiterated | Buy | $52 |
| 2026-08-06 | RBC Capital | Target lowered | Outperform | $51 → $50 |
| 2026-06-30 | RBC Capital | Target raised | Outperform | $47 → $51 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -43.5% | +110.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -43.6% | +16.0% |
| Volatility (annualized) | 52.5% | 62.5% |
| Max drawdown | -51.7% (Nov 2025→Oct 2026) | -58.9% (Jan 2023→Oct 2023) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/NAMS · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt